Each month, The Wistar Institute podcast brings you up-to-date with news and interviews concerning the scientists and research going on at one of Philadelphia's premier biomedical research institutions. We also connect you with others who share our passion about saving lives through science.
On April 5, 2016, Wistar President and CEO Dr. Dario Altieri spoke about precision medicine and how it could be used to eliminate various types of cancer. He was interviewed on Wharton Business Radio by Dan Loney, and they were joined on the phone by Dr. Carlos Arteaga, president of the American Association for Cancer Research and associate director for clinical research at Vanderbilt-Ingram Cancer Center.
On January 19, 2016, Dr. Dario Altieri spoke about the "cancer moonshot" that has the country talking since it was mentioned in this year's State of the Union Address. He was interviewed on Wharton Business Radio by Dan Loney.
In this special episode of The Wistar Institute podcast, Heather Steinman, M.B.A., Ph.D., Vice President of Business Development and Executive Director of Technology Transfer, explains her role at Wistar. According to Steinman, she hopes to find new ways of developing important relationships between Wistar scientists and industry partners that can help facilitate turning Wistar science into pratical, real-world technologies faster and more efficiently than ever before.
On this month’s podcast, we’re celebrating a new year with new scientists and new research. We’re sitting down with Andrew Hu, a recently hired associate professor, and he’s going to discuss the role that endoplasmic reticulum plays in certain types of blood cancers and how understanding it may lead to more effective treatments. We’re also discussing melanoma with Marie Webster, a postdoctoral researcher, who tells us about a paper she recently authored about cancer cells that behave like they’re dormant but may be anything but. And be sure to stay tuned after the interviews for a brief recap of recent events.
On this month’s podcast, we’re discussing breast cancer. It’s breast cancer awareness month, and while early detection has helped saved countless lives, more work needs to be done to successfully treat metastatic breast cancer. Our own Qihong Huang discusses what his lab is doing to meet the challenges posed by metastatic breast cancer and what is happening at a genetic level.
Halloween is later this week, and in honor of the special day, we have a little bit of a treat for our listeners. One sordid tale about Wistar that has persisted over the years is that a clumsy lab assistant dropped and destroyed the brain of one of America’s most influential and famous poets, Walt Whitman. We’re speaking with Dr. Brian Burrell of the University of Massachusetts who is going to tell us about the fascination of preserving brains and what really happened to Walt Whitman’s brain.
Be sure to stay tuned after the interviews for a recap of important news as well as information on some upcoming events.
On this month's episode of The Wistar Institute Podcast, we’re talking about SPORE, which stands for Special Program of Research Excellence. Wistar’s Dr. Meenhard Herlyn, who is the Caspar Wistar Professor of Melanoma Research, is leading scientific studies that will be funded through a $12.1 million SPORE grant from the National Cancer Institute. Wistar will be collaborating with the University of Pennsylvania on ground breaking skin cancer research. Dr. Herlyn is with us to discuss the SPORE grant and the project goals over the next five years.
It’s also time to start thinking about the flu. We’re talking with Dr. Scott Hensley, an assistant professor in Wistar’s vaccine center, about the parallels between ebola and seasonal flu as well as the need for getting your children vaccinated, even at early ages.
Be sure to stay tuned after the interviews for a recap of important news as well as information on some upcoming events.